01_Taller SALUD: José Vicente Castell_ISS La Fe
description
Transcript of 01_Taller SALUD: José Vicente Castell_ISS La Fe
SINERGIAS ENTRE EL SECTOR SANITARIO
(HOSPITALARIO) Y EL EMPRESARIALJOSE V. CASTELL PHD, MD
DIRECTOR
UNIVERSITY HOSPITALS :
BIOMEDICAL RESEARCH
MEDICAL TRAINING
HEALTHCARE
HIGHLY QUALIFIED PERSONNEL + ADVANCED TECHNOLOGIES
GREAT INNOVATIVE POTENTIAL …
4
Potential ideas / value run out…
Clinical care
Recovering “energy” : a co-generation model?
INNOVATION IN UNIVERSITY HOSPITALS
BIOMEDICAL RESEARCH
INNOVATIONMEDICAL TRAINING
HEALTHCARE
INTEGRATING INNOVATION IN HOSPITAL ACTIVITY
Innovation is NOT a first priority in hospitals
Innovation should be integrated and be part of
the current activity of health professionals
Support structures should be implemented in
order to “extract” potential innovations out of
clinical knowledge
Ideas / biomedical research
Strategic Validation Process
Prototypes – Proof of concept
Integration in healthcare practice
Successful
INNOVATION
is complex
Intellectual Property Rights IPRs
Clinical Validation
Commercialization
Feedback and improvement
Idea / biomedical research
Strategic Validation Process
Prototype – Proof of concept
Diffusion and adoption in Healthcare
Intellectual Property Rights IPRs
Clinical Validation
Commercialization
Feedback and improvement
Successful
INNOVATION
is complex
The clinical proof of
concept/validation
Other partners needed??
working with strategic partners
Idea Licencing-SME Valorization Commercialization
Large investments
not always affordable
Ideas Licencing-SME Valorization Commercialization
“ ”
Linking agents of the Science-
technology-Enterprise System, to
accelerate the process of
valorization, transferability and
the way to market in the field of
biomedical research
Hosting biomedical enterprises
Basic
Research
Clinical
Reseach
Valorization
and
Innovation
Transfer to
product
developers
Biopole: 15.400 m2
Medical Faculty &
Management area:
13.500m2
Medical Care area: 166.400 m2
22
SME/ IIS La Fe Partnership
CRUnit(biomedicalcontract
researchUnit )
PLATFORMS
The IIS La Fe offers scientific and technological services with more than 10,000 m2 of clinical and research laboratories
CRUnit
Omic Platform
Genomics
Cytomics
Analitycal Unit
BiomedicalResearch Support
Pre-ClinicalToxicity Platform
Cell Culture Models
Animal Models
Clinical GeneticPlatform
Pharmacogenetics
CytogeneticAnalysis
Genetic Anlysis
PRE-CLINICAL TOXICITY
PLATFORM
Cell Culture Models
Genotoxicity Hepatotoxicity Phototoxicity
Animal Models
Drug and Food Toxicity
Ecotoxicity
Coordinates preclinical or environmental studies in different levels of complexity from in vitro cellular models to animal models for a wide variety of toxicological studies.
The know-how and validated systems generated indoors are of great value in order to provide with
high quality experimental designs and accurate and reliable results promoting fast decision-making
RESEARCH OMIC
PLATFORM
Genomics
Arrays
Genotiping and Sequencing
Cytogenetics
Cytomics
Analytical Unit
Metabolics/MS
Proteomics
It is a powerful platform for the analysis, validation
and interpretation of massive data sets
Merges a set of high-tech disciplines such as Genomics, Cytomics, Metabolomics and Proteomics.
Offers a customised global GLPservice:
- including analytical services, - consultancy, as well as - the development of analytical methods
Request study
Tailoreddesign
Results in compliance
with regulation
Quick problem solvingFast-decision making
CUSTOMER NEEDS
Enzymatic activities
Biomarkers
Metabolomic profile
Secondary metabolism compounds
Signal transduction
molecules
Target molecules from
biotransformation processes
Expertise and professionals at your disposal for a wide variety of analytical determinations in compliance with GLP principles:
IDEA / PRODUCT
Stock Options or Shares, Capital return
Costs paid in valorization Procces
SHARING FUTURE VALUE
www.iislafe.es